Skip to main content

Part of the book series: Cancer Treatment and Research ((CTAR,volume 67))

Abstract

Soft tissue sarcomas (STS) can be defined as malignant tumors of nonepithelial extraskeletal tissue of the body exclusive of the reticuloendothelial system, glia, and supporting tissue of various parenchymal organs. By convention, malignant tumors of the peripheral nervous system are included because they pose similar problems in diagnosis and therapy [1]. In this chapter, we will not discuss bone and visceral sarcomas, for which diagnostic and therapeutic problems are different.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Enzinger FM, Lattes R, Torloni H: Histologic Typing of the Soft Tissue Tumors. International Classification of Tumours, no 3, Geneva, World Health Organization, 1969.

    Google Scholar 

  2. Enterline HT: Histopathology of sarcomas. Semin Oncol 8:133–155, 1981.

    PubMed  CAS  Google Scholar 

  3. Van Unnik JAM, Van Unnik AJM: Pathology of soft tissue sarcomas. In: Pinedo HM, Verweij J, eds. Clinical Management of Soft Tissue Sarcomas. Boston: Martinus Nijhoff, 1986, pp 1–27.

    Chapter  Google Scholar 

  4. Enzinger FM, Weiss SW: Soft Tissue Tumors. St Louis: CV Mosby Company, 1988.

    Google Scholar 

  5. Brooks JJ: Disorders of soft tissue. In: Sternberg SS, ed. Diagnostic Surgical Pathology. New York: Raven Press, 1989, pp 141–200.

    Google Scholar 

  6. Shiraki M, Enterline HT, Brooks JJ, Cooper NS, Hirschl S, Roth JA, Rao UN, Enzinger FM, Amato DA, Borden EC: Pathologic analysis of advanced adult soft tissue sarcomas, bone sarcomas and mesotheliomas. The Eastern Cooperative Oncology Group (ECOG) experience. Cancer 64:484–490, 1989.

    Article  PubMed  CAS  Google Scholar 

  7. Enjoji M, Hashimoto H: Diagnosis of soft tissue sarcomas. Pathol Res Pract 178:215–226, 1984.

    Article  PubMed  CAS  Google Scholar 

  8. Brooks JJ: The significance of double phenotypic patterns and markers in human sarcomas. A new model of mesenchymal differentiation. Am J Pathol 125:113–123, 1986.

    PubMed  CAS  Google Scholar 

  9. Meis JM: ‘Dedifferentiation’ in bone and soft tissue tumors. A histological indicator of tumor progression. Pathol Ann 26:37–62, 1991.

    Google Scholar 

  10. Jabi M, Jeans D, Dardick J: Ultrastructural heterogeneity in Malignant fibrous histiocytoma of soft tissue. Ultrastruct Pathol 11:583–592, 1987.

    Article  PubMed  CAS  Google Scholar 

  11. Lawson CW, Fisher C, Gatter KC: An immunohistochemical study of differentiation in malignant fibrous histiocytoma. Histopathology 11:375–383, 1986.

    Article  Google Scholar 

  12. Dehner LP: Malignant fibrous histiocytoma. Nonspecific morphologic pattern, specific pathologic entity or both? Arch Pathol Lab Med 112:236–237, 1988.

    PubMed  CAS  Google Scholar 

  13. Lieberman PH, Brennan MF, Kimmel M, Erlandson RA, Garin-Chesa P, Flehinger BY: Alveolar soft-part sarcoma. A clinico-pathologic study of half a century. Cancer 63:1–13, 1989.

    Article  PubMed  CAS  Google Scholar 

  14. Chase DR, Enzinger FM: Epithelioid sarcoma. Diagnosis, prognostic indicators and treatment. Am J Surg Pathol 9:241–263, 1985.

    Article  PubMed  CAS  Google Scholar 

  15. Fisher C: Epithelioid sarcoma: The spectrum of ultrastructural differentiation in seven immunohistochemical defined cases. Hum Pathol 19:265–275, 1988.

    Article  PubMed  CAS  Google Scholar 

  16. Chung EB, Enzinger FM: Malignant melanoma of soft parts: A reassessment of clear-cell sarcoma. Am J Surg Pathol 7:405–413, 1983.

    Article  PubMed  CAS  Google Scholar 

  17. Kindblom L, Lodding P, Angervall L: Clear-cell sarcoma of tendons and aponeuroses: An immunohistochemical and electron microscopic analysis indicating neural crest origin. Virchows Arch [A] 401:109–128, 1983.

    Article  CAS  Google Scholar 

  18. Llombart-Bosch A, Terrier-Lacombe MJ, Peydro-Olaya A, Contesso G: Peripheral neu-roectodermal sarcoma of soft tissue (peripheral neuroepithelioma): a pathologic study of ten cases with differential diagnosis regarding other small round-cell sarcomas. Hum Pathol 20:273–280, 1989.

    Article  PubMed  CAS  Google Scholar 

  19. King DR, Clatworthy HW: The pediatrie patient with sarcoma. Semin Oncol 8:215–221, 1981.

    PubMed  CAS  Google Scholar 

  20. Laskin WB, Silverman TA, Enzinger FM: Postradiation soft tissue sarcomas. An analysis of 53 cases. Cancer 62:2330–2340, 1988.

    Article  PubMed  CAS  Google Scholar 

  21. Roholl PJM, De Jong ASH, Ramaekers FCS: Application of markers in diagnosis of soft tissue tumours. Histopathology 9:1019–1035, 1985.

    Article  PubMed  CAS  Google Scholar 

  22. Brooks JJ: Immunohistochemistry in sarcomas. In: Ryan JR, Baker LO, eds. Recent Concepts in Sarcoma Treatment. Boston: Kluwer Academic, 1988, pp 48–58.

    Chapter  Google Scholar 

  23. Azumi N, Ben-Ezra J, Battifora H: Immunophenotypic diagnosis of leiomyosarcomas and rhabdomyosarcomas with monoclonal antibodies to muscle-specific actin and desmin in formalin-fixed tissue. Modern Pathol 1:469–474, 1988.

    CAS  Google Scholar 

  24. Ordonez NG, Mahfouz SM, Mackay B: Synovial sarcoma: An immunohistochemical and ultrastructural study. Hum Pathol 21:733–749, 1990.

    Article  PubMed  CAS  Google Scholar 

  25. Chase DR, Enzinger FM: Keratin in epithelioid sarcoma. An immunohistochemical study. Am J Surg Pathol 8:435–441, 1984.

    Article  PubMed  CAS  Google Scholar 

  26. Fletcher CDM: The use of immunohistochemistry in the diagnosis of soft tissue tumours. Histopathology 10:771–774, 1986.

    Article  PubMed  CAS  Google Scholar 

  27. Fisher C: The value of electronmicroscopy and immunohistochemistry in the diagnosis of soft tissue sarcomas: A study of 200 cases. Histopathology 16:441–454, 1990.

    Article  PubMed  CAS  Google Scholar 

  28. Tetu B, Hunt A, McCaughey WTE, Lagace R: Evaluation des divergences d’opinion sur le diagnostic histopathologique des tumeurs des tissus mous. Ann Pathol 4:267–271, 1984.

    PubMed  CAS  Google Scholar 

  29. Presant CA, Russell WO, Alexander RW, Fu YS: Soft-tissue and bone sarcoma histopathology peer review: The frequency of disagreement in diagnosis and the need for second pathology opinions. The Southeastern Cancer Study Group experience. J Clin Oncol 4:1658–1661, 1986.

    PubMed  CAS  Google Scholar 

  30. Russell WO, Cohen J, Enzinger F, Hajdu SI, Heise H, Martin RG, Meissner W, Miller WT, Schmitz RL, Suit HD: A clinical and pathological staging system for soft tissue sarcomas. Cancer 40:1562–1570, 1977.

    Article  PubMed  CAS  Google Scholar 

  31. Henson DE: The histological grading of neoplasms. Arch Pathol Lab Med 112:1091–1096, 1988.

    PubMed  CAS  Google Scholar 

  32. Suit HD, Mankin HJ, Schiller AL, Wood WC, Tepper JE: Staging systems for sarcoma of soft tissue and sarcoma of bone. Cancer Treat Symp 3:29–36, 1985.

    Google Scholar 

  33. Hajdu SI: History and classification of soft tissue tumors. In: Hajdu SI, ed. Pathology of Soft Tissue Tumors. Philadelphia: Lea and Febiger, 1979, pp 1–55.

    Google Scholar 

  34. Markhede G, Angervall L, Stener B: A multivariate analysis of the prognosis after surgical treatment of malignant soft tissue tumors. Cancer 49:1721–1733, 1982.

    Article  PubMed  CAS  Google Scholar 

  35. Myhre-Jensen O, Kaae S, Madsen EH, Sneppen O: Histopathological grading in soft tissue tumors. Relation to survival in 261 surgically treated patients. Acta Pathol Microbiol Immunol Scand (A) 91:145–150, 1983.

    CAS  Google Scholar 

  36. Trojani M, Contesso Gm, Coindre JM, Rouëssé J, Bui NB, de Mascarel A, Goussot JF, David M, Bonichon F, Lagarde C: Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 33:37–42, 1984.

    Article  PubMed  CAS  Google Scholar 

  37. Costa J, Wesley RA, Glatstein E, Rosenberg SA: The grading of soft tissue sarcomas. Results of a clinicopathologic correlation in a series of 163 cases. Cancer 53:530–541, 1984.

    Article  PubMed  CAS  Google Scholar 

  38. Van Unnik JAM, Coindre JM, Contesso G, Albus-Lutter CE, Schiodt T, Garcia-Miralles T, Sylvester R, Thomas D, Bamwell V: Grading of soft tissue sarcomas: experience of the EORTC soft tissue and bone sarcoma Group. In: Ryan JR, Baker LO, eds. Recent Concepts in Sarcoma Treatment. Boston: Kluwer Academic, 1988, pp 7–13.

    Chapter  Google Scholar 

  39. Coindre JM, Trojani M, Contesso G, David M, Rouëssé J, Bui NB, Bodaert A, de Mascarel I, de Mascarel A, Goussot JF: Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer 58:306–309, 1986.

    Article  PubMed  CAS  Google Scholar 

  40. Henson DE: Grading of tumors. Arch Pathol Lab Med 112:769–770, 1988.

    PubMed  CAS  Google Scholar 

  41. Lindberg RD, Martin RG, Romsdahl MM: Conservative surgery and postoperative radiotherapy in 300 adults with soft-tissue sarcomas. Cancer 47:2391–2397, 1981.

    Article  PubMed  CAS  Google Scholar 

  42. Suit HD, Mankin HJ, Schiller AL, Wood WC, Tepper JE, Gebhardt MC: Results of treatment of sarcoma of soft tissue by radiation and surgery at Massachusetts General Hospital. Cancer Treat Symp 3:43–47, 1985.

    Google Scholar 

  43. Rööser BO, Attewell R, Berg NO, Rydholm A: Prognostication in soft tissue sarcoma. A model with four risk factors. Cancer 61:817–823, 1988.

    Article  PubMed  Google Scholar 

  44. Mandard AM, Petiot JF, Marnay J, Mandard JC, Chasle J, de Ranieri E, Dupin P, Herlin P, de Ranieri J, Tanguy A, Boulier N, Abbatucci JS: Prognostic factors in soft tissue sarcomas. A multivariate analysis of 109 cases. Cancer 63:1437–1451, 1989.

    Article  PubMed  CAS  Google Scholar 

  45. Ravaud A, Bui NB, Coindre JM, Lagarde P, Stockle E, Maree D: Tumor depth and tumor grade as the main significant prognostic factors in metastase-free survival and overall survival in soft tissue sarcomas. Eur J Cancer 27(Suppl 2):S161, 1991.

    Google Scholar 

  46. Heise HW, Myers MH, Russell WO, Suit HD, Enzinger FM, Edmonson JH, Cohen J, Martin RG, Miller WT, Hajdu SI: Recurrence-free survival time for surgically treated soft tissue sarcoma patients. Multivariate analysis of five prognostic factors. Cancer 57:172–177, 1986.

    Article  PubMed  CAS  Google Scholar 

  47. Collin C, Godbold J, Hajdu S, Brennan M: Localized extremity soft tissue sarcoma: An analysis of factors affecting survival. J Clin Oncol 5:601–612, 1987.

    PubMed  CAS  Google Scholar 

  48. Tsujimoto M, Aozasa K, Ueda T, Morimura Y, Komatsubara Y, Doi T: Multivariate analysis for histologic prognostic factors in soft tissue sarcomas. Cancer 62:994–998, 1988.

    Article  PubMed  CAS  Google Scholar 

  49. Lack EE, Steinberg SM, White DE, Kinsella T, Glatstein E, Chang AE, Rosenberg SA: Extremity soft tissue sarcomas: Analysis of prognostic variables in 300 cases and evaluation of tumor necrosis as a factor in stratifying higher-grade sarcomas. J Surg Oncol 41: 263–273, 1989.

    Article  PubMed  CAS  Google Scholar 

  50. Elias A, Ryan L, Sulkes A, Collins J, Aisner J, Antman KH: Response to mesna, doxorubicin, ifosfamide and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy. J Clin Oncol 7:1208–1216, 1989.

    PubMed  CAS  Google Scholar 

  51. Ravaud A, Bui NB, Coindre JM, Kantor G, Stockle E, Lagarde P, Bécouarn Y, Chauvergne J, Bonichon F, Maree D: Adjuvant chemotherapy with Cyvadic in high risk soft tissue sarcoma: A randomized prospective trial. In: Salmon SE, ed. Adjuvant Therapy of Cancer. Philadelphia: WB Saunders, 1990, pp 556–566.

    Google Scholar 

  52. Cany L, Bui NB, Maree D, Coindre JM, Kantor G, Ravaud A: Conservative combined therapy with neo-adjuvant chemotherapy for locally advanced soft tissue sarcomas. Results in a series of 64 patients. Eur J Cancer 27(Suppl 2):S163, 1991.

    Google Scholar 

  53. Terrier P, Terrier-Lacombe MJ, Mouriesse H, Friedman S, Spielmann M, Contesso G: Primary breast sarcoma: a review of 33 cases with immunohistochemistry and prognostic factors. Breast Cancer Res Treat 13:39–48, 1989.

    Article  PubMed  CAS  Google Scholar 

  54. Wilson RE, Antman KH, Brodsky G, Greenberger JS: Tumor-cell heterogeneity in soft tissue sarcomas as defined by chemotherapy. Cancer 53:1420–1425, 1984.

    Article  PubMed  CAS  Google Scholar 

  55. Coindre JM, Bui NB, Goussot JF, de Mascarel I, Maree D, de Mascarel A, Trojani M: Modifications histologiques apres chimiotherapie des sarcomes des tissue mous de l’adulte. Ann Pathol 5:95–99, 1985.

    PubMed  CAS  Google Scholar 

  56. Sahin AA, Ro JY, El-Naggar AK, Wilson PL, Teague K, Blick M, Ayala AG: Tumor proliferative fraction in solid malignant neoplasms. A comparative study of Ki-67 immuno-staining and flow cytometry determinations. Am J Clin Pathol 96:512–519, 1991.

    PubMed  CAS  Google Scholar 

  57. Garcia RL, Coltrera MD, Gown AM: Analysis of proliferative grade using anti-PCNA/cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analysis. Am J Pathol 134:733–739, 1989.

    PubMed  CAS  Google Scholar 

  58. Cance WG, Brennan MF, Dudas ME, Huang CM, Cordon-Cardo C: Altered expression of the retinoblastoma gene product in human sarcomas. N Engl J Med 323:1457–1462, 1990.

    Article  PubMed  CAS  Google Scholar 

  59. Chan HSL, Thorner PS, Haddad G, Ling V: Immunohistochemical detection of P-glyco-protein: prognostic correlation in soft tissue sarcoma of childhood. J Clin Oncol 8:689–704, 1990.

    PubMed  CAS  Google Scholar 

  60. Non-Hodgkin’s Lymphoma Pathologic Classification Project: National Institute-sponsored study of classifications of non-Hodgkin’s lymphomas: summary and description of a working formulation for clinical usage, 1982. Cancer 49:2112–2135, 1982.

    Article  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer Science+Business Media New York

About this chapter

Cite this chapter

Coindre, J.M. (1993). Pathology and grading of soft tissue sarcomas. In: Verweij, J., Pinedo, H.M., Suit, H.D. (eds) Multidisciplinary Treatment of Soft Tissue Sarcomas. Cancer Treatment and Research, vol 67. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3082-4_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-3082-4_1

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6346-0

  • Online ISBN: 978-1-4615-3082-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics